157
Participants
Start Date
January 28, 2014
Primary Completion Date
January 25, 2019
Study Completion Date
May 21, 2019
Vedolizumab
Vedolizumab IV injection
Vedolizumab placebo
Vedolizumab placebo-matching IV infusion
Nagoya
Toyota
Hirosaki
Abiko
Kashiwa
Sakura
Matsuyama
Chikushino-shi
Kasuga
Kitakyushu
Takasaki
Fukuyama
Hatsukaichi
Asahikawa
Sapporo
Tomakomai
Akashi
Nishinomiya
Takamatsu
Kamakura
Kawasaki
Sagamihara
Yokohama
Kochi
Sendai
Kurashiki
Moriguchi
Suita
Tokorozawa
Ōtsu
Hamamatsu
Shimotsuke
Adachi-ku
Bunkyo-ku
Chiyoda-ku
Minato-ku
Shinagawa-ku
Shinjuku-ku
Shūnan
Kofu
Chiba
Fukui
Fukuoka
Hiroshima
Kagoshima
Kumamoto
Kyoto
Nagasaki
Niigata
Okayama
Okinawa
Osaka
Ōita
Saga
Saitama
Wakayama
Lead Sponsor
Takeda
INDUSTRY